This book covers ACS and Heart Failure, the chapters represent the most current, up to date and knowledgeable content on the topic available. It is written by the worlds most respected leaders in biomarkers, with a majority emphasis on what clinicians need to know.
The Editors and their contributors have provided algorithms, annotated case discussions and caveats. They cover biomarkers to predict risk of heart disease, biomarkers of cardiorenal disease , and conclude with a section on new and emerging biomarkers. It be genuinely helpful and practical to those in the field, including not just people working in the field, but nurses, doctors, etc who practice medicine in the clinic, the emergency department and the hospital.​ Common terms and phrases: 99th percentile acute addition admission analytical apoB assays assessment associated atrial fibrillation baseline biomarkers blood cancer cardiac troponin Cardiol cardiovascular cause changes chest pain chronic Circulation Clin clinical Coll compared concentrations coronary coronary artery cTnI cTnT death decreased detection diabetes diagnosis disease dysfunction dyspnea early effects elevated emergency department et al evaluation factors function heart failure high sensitivity higher hospital hs-cTn hypertension identify important improved increased individuals initial injury laboratory left ventricular levels limit lower LVEF markers measurement months mortality myocardial infarction natriuretic peptide ng/L ng/ml normal NT-proBNP outcomes patients pg/mL population potential predictive presentation prognostic pulmonary recent reduced reference renal reported risk role sarcopenia screening serial setting showed shown significant specific suggested symptoms syndrome testing therapy tion treatment utility